Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hunter Smith Insider Profile
4 Followers
Hunter Smith, Director at Genesee & Wyoming, holds 97.94K shares in Rhythm Pharmaceuticals (Ticker: RYTM), holds 0.00 shares in Genesee & Wyoming (Ticker: GWR), holds ― shares in Spyre Therapeutics (Ticker: SYRE).
Profitable Transactions
5 out of 9 Profitable Transactions
Average Return
+16.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Hunter Smith holds in companies
Most Profitable Insider Trade
The most profitable trade made by Hunter Smith
Hunter Smith's Trading History
Genesee & Wyoming
Dec 30, 2019
―
Uninformative Sell
1.32M
$0.00
Rhythm Pharmaceuticals
Mar 19, 2024
CFO
Uninformative Sell
608.50K
$4.30M
Spyre Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Hunter Smith's performance on stock
You May Also Like
Hunter Smith insider profile FAQ
What is the percentage of profitable transactions made by Hunter Smith?
The percentage of profitable transactions made by Hunter Smith is 56%.
What is the average return per transaction made by Hunter Smith?
The average return per transaction made by Hunter Smith is 16.40%.
What stocks does Hunter Smith hold?
Hunter Smith holds: GWR, RYTM, SYRE stocks.
What was Hunter Smith’s latest transaction?
Hunter Smith latest transaction was an Uninformative Sell of $608.50K.
What was Hunter Smith's most profitable transaction?
Hunter Smith’s most profitable transaction was an Informative Buy of RYTM stock on June 21, 2023. The return on the trade was 136.90%.
What is Hunter Smith's role in Genesee & Wyoming?
Hunter Smith's role in Genesee & Wyoming is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.